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EDITORIALMacrophages: The Missing Link in Diabetic Gastroparesis?astroparesis is a clinical condition associated withGdelayed gastric emptying in the absence of me-
chanical obstruction. Patients present with nausea, vomit-
ing, bloating, and early satiety. The underlying cause may be
related to diabetes but also can be caused by upper
gastrointestinal surgery, neurologic disease, collagen
vascular disease, viral infections, and drugs.1 In approxi-
mately 35% of patients there is no underlying cause.
The pathogenesis and underlying cellular changes in dia-
betic gastroparesis are largely unknown. Changes in neu-
rons, the interstitial cells of Cajal (ICC), and intestinal
smooth muscle have been believed to have shown in dia-
betic gastroparesis. Macrophages have been believed to play
some role in the development of diabetic gastroparesis but
the mechanisms are not known.
In the article by Cipriani et al,2 data are presented to
support the role of macrophages in the development of
delayed gastric emptying. Cipriani et al show the concept
that macrophages are necessary for the pathogenesis of
delayed gastric emptying. To do this, they used the Csf1op/op
mice that lack biologically active macrophage-colony stim-
ulating factor Csf1, resulting in the absence of Csf1-
dependent tissue macrophages. Absence of macrophages
in the muscle layer of the small intestine of these mice has
been shown previously. Mice were injected with strepto-
zotocin to make them diabetic and gastric emptying was
assessed weekly. In addition, macrophages were identiﬁed
by immunostaining and oxidative stress and messenger RNA
levels were measured. The study showed that Csf1op/op mice
have normal ICCs. When diabetes is induced there is
increased oxidative stress in both the wild-type Csf1þ/þ
mice and the Csf1op/op mice. Interestingly, despite this
increased oxidative stress, the Csf1op/op mice did not
develop loss of ICCs and the consequent delayed gastric
emptying, however, the wild-type mice did. This led to the
conclusion that the presence of muscle layer macrophages is
required for the development of diabetic gastroparesis.
This work helps us to further understand the patho-
physiology of diabetic gastroparesis with a focus on the
muscle layer macrophages. It strengthens the role of ICC
injury in diabetic gastroparesis and thereby highlights
targets for the prevention and treatment of gastroparesis.
Macrophages present in the muscle layer can be polar-
ized in response to changes in the microenvironment and
are classiﬁed as M1 (proinﬂammatory macrophages) and
M2 (anti-inﬂammatory macrophages). A previous study by
Choi et al3 showed that CD206-positive M2 macrophages
are very important in preventing diabetic gastroparesis and
this appears to be owing due to a heme oxygenase–
dependent mechanism. Interestingly, in human beings, the
number of CD206-positive M2 macrophages correlates with
the number of ICCs, and this in turn correlates with gastricCemptying.4 In the Csf1op/op mice the baseline gastric
emptying time was less that of the wild-type mice. It was
noted that with the induction of diabetes in the Csf1op/op
mice there was no reduction in gastric emptying. This was
despite evidence for increased oxidative stress in these mice
to the levels seen in the wild-type (WT) mice with delayed
gastric emptying. The WT mice without delayed gastric
emptying had lower oxidative stress levels, indicating that
oxidative stress does play a role in diabetes-related delayed
gastric emptying. The ﬁndings in this study suggest that
the M1 macrophages may be releasing proinﬂammatory
cytokines, which are required for the streptozotocin-
induced damage to the ICCs noted in the wild-type but not
Csf1op/op mice. This protection was seen despite the mice
being equally hyperglycemic and having similar levels of
oxidative stress. The lack of macrophages could protect
against the loss of ICCs induced by streptozotocin. One point
to be noted is that the Csf1op/op mice had developmental
abnormalities including failure to develop teeth and some
skeletal abnormalities. The investigators did ensure that the
mice completed at least 50% of the meal to ensure com-
parable gastric emptying data between WT and Csf1op/op
mice.
In summary, the study showed a role for macrophages in
regulating the changes in the ICCs in diabetic gastroparesis,
suggesting the role of M1 macrophages. Resident macro-
phages also could have a role in regulating gastrointestinal
muscle contraction.5 Future studies will need to examine
the role of macrophages in other models of type 1 and type
2 diabetes. The current study advances the understanding of
the complex pathophysiology of diabetic gastroparesis,
focusing on the role of macrophages, and opens up a new
area of research and potential therapeutic targets.
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